DESKi's HeartFocus: A Game Changer in Cardiac Diagnostics
June 19, 2025, 9:34 am
In the world of healthcare, timing is everything. Early detection can mean the difference between life and death. Enter DESKi, a Bordeaux-based HealthTech company that is shaking up the cardiac imaging landscape. With its recent €5.2 million Seed funding, DESKi is poised to make waves in the U.S. and global markets with its innovative software, HeartFocus.
Founded in 2016 by brothers Bertrand and Olivier Moal, DESKi is on a mission. They aim to tackle one of the most pressing issues in healthcare: the accessibility of cardiac diagnostics. Heart disease is the leading cause of death worldwide. Yet, access to echocardiography is often limited. Trained specialists are in short supply, especially in rural and underserved areas. HeartFocus seeks to bridge this gap.
The software is not just another tool; it’s a lifeline. HeartFocus leverages advanced AI algorithms trained on over 10 million data points. This technology allows healthcare professionals, even those with minimal training, to perform cardiac ultrasounds. Imagine a world where a nurse in a rural clinic can capture diagnostic-quality heart scans after just a few hours of training. That’s the promise of HeartFocus.
The recent funding round was led by Racine², an impact-focused fund. Other notable participants included BNP Paribas Développement, Épopée Gestion, and Good Only Ventures. This diverse group of investors recognizes the potential of HeartFocus to transform cardiac care. They see it as a tool that can democratize access to life-saving diagnostics.
HeartFocus recently received FDA clearance, a significant milestone. This approval is not just a rubber stamp; it’s a gateway to the U.S. market. The software also comes with a Predetermined Change Control Plan (PCCP), which simplifies future updates. This means HeartFocus can evolve over time, adapting to new challenges and technologies.
Clinical studies have shown promising results. Even first-time users, guided by HeartFocus AI, can achieve diagnostic-quality scans. This is revolutionary. It empowers healthcare providers at all levels to deliver timely and accurate diagnoses. The implications are vast. Early detection can lead to early intervention, ultimately saving lives.
The Moal brothers are not just tech entrepreneurs; they are driven by a personal mission. Their backgrounds in medicine and engineering fuel their passion for improving healthcare. They understand the stakes. Cardiovascular disease is a silent killer, often going undetected until it’s too late. HeartFocus aims to change that narrative.
The potential applications of HeartFocus are broad. It can be used in primary care settings, rural clinics, and even in emergency situations. The software’s flexibility means it can be deployed in various environments, making it a versatile tool in the fight against heart disease.
Investors are excited about the prospects. They see HeartFocus as a solution that improves the patient journey. Faster access to diagnostics means better care at lower costs. This aligns with the growing trend in healthcare: a shift towards patient-centered solutions.
As DESKi prepares for its global launch, the company is also forming partnerships. Collaborations with U.S. and European app platforms will enhance the software’s reach. This strategy is crucial. The more healthcare providers that can access HeartFocus, the greater the impact on patient outcomes.
The road ahead is promising but not without challenges. The healthcare landscape is complex. Regulatory hurdles, market competition, and the need for continuous innovation are just a few obstacles DESKi will face. However, the company’s commitment to improving cardiac care is unwavering.
HeartFocus is more than just a product; it’s a vision for the future of healthcare. It embodies the idea that technology can empower healthcare professionals and save lives. As DESKi moves forward, it carries the hopes of many. The journey from clinical validation to real-world impact is a significant leap, but one that DESKi is ready to take.
In conclusion, DESKi’s HeartFocus represents a beacon of hope in the fight against heart disease. With its innovative technology and strong backing, the company is set to redefine cardiac diagnostics. The future looks bright, and the potential for impact is immense. As HeartFocus rolls out globally, it could very well change the landscape of cardiac care forever. The heart of healthcare is beating stronger, thanks to DESKi.
Founded in 2016 by brothers Bertrand and Olivier Moal, DESKi is on a mission. They aim to tackle one of the most pressing issues in healthcare: the accessibility of cardiac diagnostics. Heart disease is the leading cause of death worldwide. Yet, access to echocardiography is often limited. Trained specialists are in short supply, especially in rural and underserved areas. HeartFocus seeks to bridge this gap.
The software is not just another tool; it’s a lifeline. HeartFocus leverages advanced AI algorithms trained on over 10 million data points. This technology allows healthcare professionals, even those with minimal training, to perform cardiac ultrasounds. Imagine a world where a nurse in a rural clinic can capture diagnostic-quality heart scans after just a few hours of training. That’s the promise of HeartFocus.
The recent funding round was led by Racine², an impact-focused fund. Other notable participants included BNP Paribas Développement, Épopée Gestion, and Good Only Ventures. This diverse group of investors recognizes the potential of HeartFocus to transform cardiac care. They see it as a tool that can democratize access to life-saving diagnostics.
HeartFocus recently received FDA clearance, a significant milestone. This approval is not just a rubber stamp; it’s a gateway to the U.S. market. The software also comes with a Predetermined Change Control Plan (PCCP), which simplifies future updates. This means HeartFocus can evolve over time, adapting to new challenges and technologies.
Clinical studies have shown promising results. Even first-time users, guided by HeartFocus AI, can achieve diagnostic-quality scans. This is revolutionary. It empowers healthcare providers at all levels to deliver timely and accurate diagnoses. The implications are vast. Early detection can lead to early intervention, ultimately saving lives.
The Moal brothers are not just tech entrepreneurs; they are driven by a personal mission. Their backgrounds in medicine and engineering fuel their passion for improving healthcare. They understand the stakes. Cardiovascular disease is a silent killer, often going undetected until it’s too late. HeartFocus aims to change that narrative.
The potential applications of HeartFocus are broad. It can be used in primary care settings, rural clinics, and even in emergency situations. The software’s flexibility means it can be deployed in various environments, making it a versatile tool in the fight against heart disease.
Investors are excited about the prospects. They see HeartFocus as a solution that improves the patient journey. Faster access to diagnostics means better care at lower costs. This aligns with the growing trend in healthcare: a shift towards patient-centered solutions.
As DESKi prepares for its global launch, the company is also forming partnerships. Collaborations with U.S. and European app platforms will enhance the software’s reach. This strategy is crucial. The more healthcare providers that can access HeartFocus, the greater the impact on patient outcomes.
The road ahead is promising but not without challenges. The healthcare landscape is complex. Regulatory hurdles, market competition, and the need for continuous innovation are just a few obstacles DESKi will face. However, the company’s commitment to improving cardiac care is unwavering.
HeartFocus is more than just a product; it’s a vision for the future of healthcare. It embodies the idea that technology can empower healthcare professionals and save lives. As DESKi moves forward, it carries the hopes of many. The journey from clinical validation to real-world impact is a significant leap, but one that DESKi is ready to take.
In conclusion, DESKi’s HeartFocus represents a beacon of hope in the fight against heart disease. With its innovative technology and strong backing, the company is set to redefine cardiac diagnostics. The future looks bright, and the potential for impact is immense. As HeartFocus rolls out globally, it could very well change the landscape of cardiac care forever. The heart of healthcare is beating stronger, thanks to DESKi.